Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.92% | -6.50% | 93.79% | -1,956.80% | -4.86% |
| Total Depreciation and Amortization | -0.46% | 0.07% | -59.95% | 118.36% | 2.70% |
| Total Amortization of Deferred Charges | -0.51% | 1.99% | -1.55% | -11.74% | 36.94% |
| Total Other Non-Cash Items | -16.44% | 60.01% | -97.01% | 1,974.78% | -18.86% |
| Change in Net Operating Assets | 134.38% | -120.08% | -131.62% | 420.22% | 80.83% |
| Cash from Operations | 383.27% | -846.34% | -102.02% | 208.63% | 152.13% |
| Capital Expenditure | -5.26% | -6.92% | 30.06% | -2.22% | 85.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -100.00% | 193.40% |
| Cash from Investing | -5.37% | -4.57% | -107.80% | 1,037.61% | 85.52% |
| Total Debt Issued | -- | -- | -- | -89.15% | -- |
| Total Debt Repaid | 100.00% | -- | -- | 31.80% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18,571.43% | 99.61% | -3,031.03% | 99.86% | -144,696.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | 58.26% |
| Other Financing Activities | -229.01% | 54.29% | -188.26% | 284.04% | 68.96% |
| Cash from Financing | 58.60% | -176.69% | 95.73% | -122.49% | -368.41% |
| Foreign Exchange rate Adjustments | -39.05% | 53.48% | -161.78% | -11.94% | -142.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 152.74% | -128.23% | -131.71% | 207.80% | 64.99% |